Literature DB >> 7542971

Side-firing devices for laser prostatectomy. An overview.

C F van Swol1, R M Verdaasdonk, R J van Vliet, D G Molenaar, T A Boon.   

Abstract

Transurethral laser coagulation of the prostate has become an accepted treatment for benign prostatic hyperplasia (BPH). The most common method is the use of a sideward-firing fiber that, once inserted in the prostatic area, irradiates the abundant prostatic tissue with Nd:YAG laser light. In this study, eight different side-firing fibers that are commercially available were evaluated. The devices can be characterized by the way laser light is deflected sideward and by their thermal behavior. Most of the eight devices differ with regard to the angle at which the laser beam is deflected, the spot size on the irradiated tissue surface, and the heating of the device itself. Implementation of the optical and thermal characteristics of each device in the treatment protocol will contribute to the optimal use of laser energy for prostatectomy.

Entities:  

Mesh:

Year:  1995        PMID: 7542971     DOI: 10.1007/bf00183620

Source DB:  PubMed          Journal:  World J Urol        ISSN: 0724-4983            Impact factor:   4.226


  1 in total

1.  Transurethral ultrasound-guided laser-induced prostatectomy (TULIP procedure): a canine prostate feasibility study.

Authors:  R A Roth; H T Aretz
Journal:  J Urol       Date:  1991-10       Impact factor: 7.450

  1 in total
  3 in total

1.  On the Merits of Using Angled Fiber Tips in Office-based Laser Surgery of the Vocal Folds.

Authors:  Isabelle A Chan; Jesse F d'Almeida; Alex J Chiluisa; Thomas L Carroll; Yuxiang Liu; Loris Fichera
Journal:  Proc SPIE Int Soc Opt Eng       Date:  2021-02-15

2.  Fabrication of multipoint side-firing optical fiber by laser micro-ablation.

Authors:  Hoang Nguyen; Md Masud Parvez Arnob; Aaron T Becker; John C Wolfe; Matthew K Hogan; Philip J Horner; Wei-Chuan Shih
Journal:  Opt Lett       Date:  2017-05-01       Impact factor: 3.776

3.  Tunable plasmonic nanoprobes for theranostics of prostate cancer.

Authors:  Ekaterina Y Lukianova-Hleb; Alexander O Oginsky; Adam P Samaniego; Derek L Shenefelt; Daniel S Wagner; Jason H Hafner; Mary C Farach-Carson; Dmitri O Lapotko
Journal:  Theranostics       Date:  2011-01-10       Impact factor: 11.556

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.